 |
Cores and Resources Serving UCLA
|
|
 |
 |
|
Department / Division Affiliations
| |
Associate Director,
UCLA Vector Core
| |
Assistant Adjunct Professor,
Medicine
|
|
Publications:
Logg Christopher R, Robbins Joan M, Jolly Douglas J, Gruber Harry E, Kasahara Noriyuki Retroviral replicating vectors in cancer..
Methods in Enzymology.
2012; 507:
199-228.
Kimura Takahiro, Hiraoka Kei, Kasahara Noriyuki, Logg Christopher R Optimization of enzyme-substrate pairing for bioluminescence imaging of gene transfer using Renilla and Gaussia luciferases..
Journal of Gene Medicine.
2010; 12(6):
528-37.
Tai C-K, Wang W, Lai Y-H, Logg CR, Parker WB, Li Y-F, Hong JS, Sorscher EJ, Chen TC, Kasahara N Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene..
Cancer Gene Therapy.
2010; 17(9):
614-23.
Haga Kazunori, Tomioka Atsushi, Liao Chun-Peng, Kimura Takahiro, Matsumoto Hiroshi, Ohno Izumi, Hermann Kip, Logg Christopher R, Jiao Jing, Tanaka Motoyoshi, Hirao Yoshihiko, Wu Hong, Kruse Carol A, Roy-Burman Pradip, Kasahara Noriyuki PTEN knockout prostate cancer as a model for experimental immunotherapy..
Journal of Urology.
2009; 181(1):
354-62.
Logg Christopher R, Baranick Brian T, Lemp Nathan A, Kasahara Noriyuki Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing..
Journal of Molecular Biology.
2007; 369(5):
1214-29.
Kikuchi Eiji, Menendez Silvia, Ozu Choichiro, Ohori Makoto, Cordon-Cardo Carlos, Logg Christopher R, Kasahara Noriyuki, Bochner Bernard H Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors..
Clinical Cancer Research.
2007; 13(15 Pt 1):
4511-8.
Hiraoka Kei, Kimura Takahiro, Logg Christopher R, Tai Chien-Kuo, Haga Kazunori, Lawson Gregory W, Kasahara Noriyuki Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model..
Cancer Research.
2007; 67(11):
5345-53.
Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts..
Cancer Gene Therapy.
2007; 14(3):
279-86.
Haga K, Lemp NA, Logg CR, Nagashima J, Faure-Kumar E, Gomez GG, Kruse CA, Mendez R, Stripecke R, Kasahara N, Kasahara N, Cicciarelli JC Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs: Averting cytotoxicity by alloreactive T lymphocytes..
Transplantation Proceedings.
2006; 38(10):
3184-8.
Hiraoka Kei, Kimura Takahiro, Logg Christopher R, Kasahara Noriyuki Tumor-selective gene expression in a hepatic metastasis model after locoregional delivery of a replication-competent retrovirus vector..
Clinical Cancer Research.
2006; 12(23):
7108-16.
Dalba Charlotte, Klatzmann David, Logg Christopher R, Kasahara Noriyuki Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors..
Current Gene Therapy.
2005; 5(6):
655-67.
Logg Christopher R, Kasahara Noriyuki Retrovirus-mediated gene transfer to tumors: utilizing the replicative power of viruses to achieve highly efficient tumor transduction in vivo..
Methods in Molecular Biology.
2004; 246(3):
499-525.
Tai Chien-Kuo, Logg Christopher R, Park Jinha M, Anderson W French, Press Michael F, Kasahara Noriyuki Antibody-mediated targeting of replication-competent retroviral vectors..
Human Gene Therapy.
2003; 14(8):
789-802.
Logg CR, Logg A, Matusik RJ, Bochner BH, Kasahara N Tissue-specific transcriptional targeting of a replication-competent retroviral vector..
Journal of Virology.
2002; 76(24):
12783-91.
Soifer Harris, Higo Collin, Logg Christopher R, Jih Lily Ja-Lu, Shichinohe Toshiaki, Harboe-Schmidt Erik, Mitani Kohnosuke, Kasahara Noriyuki A novel, helper-dependent, adenovirus-retrovirus hybrid vector: stable transduction by a two-stage mechanism..
Molecular Therapy.
2002; 5(5 Pt 1):
599-608.
Chang Z, Pan J, Logg C, Kasahara N, Roy-Burman P A replication-competent feline leukemia virus, subgroup A (FeLV-A), tagged with green fluorescent protein reporter exhibits in vitro biological properties similar to those of the parental FeLV-A..
Journal of Virology.
2001; 75(18):
8837-41.
Logg CR, Logg A, Tai CK, Cannon PM, Kasahara N Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary..
Journal of Virology.
2001; 75(15):
6989-98.
Logg CR, Tai C K, Logg A, Anderson WF, Kasahara N A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors..
Human Gene Therapy.
2001; 12(8):
921-32.
Smith E, Redman RA, Logg CR, Coetzee GA, Kasahara N, Frenkel B Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes..
The Journal of Biological Chemistry.
2000; 275(26):
19992-20001.
|
|
|
 |
 |
 |
|